Erasca Inc - ESG Rating & Company Profile powered by AI
The report of Erasca Inc incorporates data from across the web and also from available filings by Erasca Inc. Alternative corporations in the rating peer group for Erasca Inc are shown. The Sustainability assessment for Erasca Inc represents its transparency towards the United Nations SDGs.
Erasca Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.7; made up of an environmental score of 1.3, social score of 1.1 and governance score of 2.7.
1.7
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1631 | Viewbix Inc | 1.8 | Low |
1631 | dorsaVi Ltd | 1.8 | Low |
1682 | Erasca Inc | 1.7 | Low |
1682 | C4 Therapeutics Inc | 1.7 | Low |
1682 | Abcellera Biologics Inc | 1.7 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Erasca Inc have an accelerator or VC vehicle to help deliver innovation?
Does Erasca Inc disclose current and historical energy intensity?
Does Erasca Inc report the average age of the workforce?
Does Erasca Inc reference operational or capital allocation in relation to climate change?
Does Erasca Inc disclose its ethnicity pay gap?
Does Erasca Inc disclose cybersecurity risks?
Does Erasca Inc offer flexible work?
Does Erasca Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Erasca Inc disclose the number of employees in R&D functions?
Does Erasca Inc conduct supply chain audits?
Does Erasca Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Erasca Inc conduct 360 degree staff reviews?
Does Erasca Inc disclose the individual responsible for D&I?
Does Erasca Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Erasca Inc disclose current and / or historical scope 2 emissions?
Does Erasca Inc disclose water use targets?
Does Erasca Inc have careers partnerships with academic institutions?
Did Erasca Inc have a product recall in the last two years?
Does Erasca Inc disclose incidents of discrimination?
Does Erasca Inc allow for Work Councils/Collective Agreements to be formed?
Has Erasca Inc issued a profit warning in the past 24 months?
Does Erasca Inc disclose parental leave metrics?
Does Erasca Inc disclose climate scenario or pathway analysis?
Does Erasca Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Erasca Inc disclose the pay ratio of women to men?
Does Erasca Inc support suppliers with sustainability related research and development?
Does Erasca Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Erasca Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Erasca Inc involved in embryonic stem cell research?
Does Erasca Inc disclose GHG and Air Emissions intensity?
Does Erasca Inc disclose its waste policy?
Does Erasca Inc report according to TCFD requirements?
Does Erasca Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Erasca Inc disclose energy use targets?
Does Erasca Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Erasca Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Erasca Inc
These potential risks are based on the size, segment and geographies of the company.
Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. It is also developing ERAS-801, a central nervous system-penetrant EGFR inhibitor for the treatment of patients with recurrent glioblastoma multiforme. The company was incorporated in 2018 and is headquartered in San Diego, California.